Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2018

View Archived Issues

Cognitive, somatic stabilization by treatment with IgG-IDUA fusion protein in children with MPS I

Aging, ARCH and AML

Specific redox enzyme helps reverse fibrosis

A designer supramolecule AK-750 amplifies innate immune responses in preclinical models of cancer

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

Novel mouse model of miR-7-induced pancreatic beta-cell dedifferentiation

Animal model of HAAF provides insight on pathological process of the disease

Longitudinal study confirms fat, disputes sugar as obesity cause in mice

Rimeporide well tolerated in boys with Duchenne muscular dystrophy

Concentric Analgesics initiates phase II trial of CA-008 to treat postsurgical pain

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

Neurotrope initiates enrollment in confirmatory phase II study of bryostatin-1

RegenxBio initiates first-in-human trial of RGX-111 for treatment of MPS I

Phase III CREDENCE trial of Invokana stopped early due to promising outcomes

Researchers present clinical data for RG-7916 in patients with SMA

Destiny Pharma and Aston University establish biofilm research collaboration

CAPSTONE-2 influenza trial of baloxavir marboxil meets primary objective

Pfizer begins pivotal phase III program for fidanacogene elaparvovec in hemophilia B

Longevity Biotech launches clinical neuroinflammation biomarker study

Spero awarded funding to develop SPR-994

Abbisko Therapeutics patents FGFR-4 inhibitors

Nanjing Carephar Shenghui Pharmaceutical Co. divulges RORgammaT antagonists

Bayer divulges new B1 receptor antagonists

Orion presents CYP11A1 inhibitors

Lundbeck discloses PDE1 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...